Skip to main content
SpringerLink
Log in

Vernakalant IV approved for reimbursement in Belgium

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cardiome Pharma. Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities. Media Release : 9 Apr 2015. Available from: URL: http://www.cardiome.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vernakalant IV approved for reimbursement in Belgium. PharmacoEcon Outcomes News 726, 36 (2015). https://doi.org/10.1007/s40274-015-2084-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2084-z

Search

Navigation